Stroke cuts life expectancy by one third: Australian study

Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, promptin...

April 15, 2022 | Friday | News
Singapore's Juniper Biologics to offer world's first cell-mediated gene therapy for knee osteoarthritis

Juniper Biologics, a Singapore-based science-led healthcare company, has gained the licensing rights to develop and...

April 13, 2022 | Wednesday | News
Australia develops wireless neuro-stimulator to revolutionise patient care

Many neurological disorders like Parkinson’s, chronic depression and other psychiatric conditions could be managed...

April 12, 2022 | Tuesday | News
Australia finds antimicrobial resistance making UTIs more deadly

A new study led by Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisati...

April 7, 2022 | Thursday | News
Rona Therapeutics raises $33 million in Series A

China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...

April 7, 2022 | Thursday | News
Hong Kong highlights significant global incidence of newly diagnosed type 1 diabetes

One of the largest global studies of its kind, led by The Chinese University of Hong Kong (CUHK)’s Faculty of Medi...

April 6, 2022 | Wednesday | News
Australia launches flagship biological storage facility 'Biobanking Victoria'

Monash University has officially launched Australia’s first industry-focused storage facility for biological mater...

April 6, 2022 | Wednesday | News
Exploring the Possibilities of RNA Therapeutics

The success of the mRNA vaccine against COVID-19 has skyrocketed the development of RNA therapies. In 2021, more than 60...

April 2, 2022 | Saturday | News
CHA Medical & Bio Group opens new cell gene biobank facility in Korea

CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea...

March 31, 2022 | Thursday | News
Taiwan accepts CANbridge's NDA for Alagille Syndrome

CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...

March 29, 2022 | Tuesday | News
Australia explores changes in brain under influence of psychedelic drugs

It is well known that ingesting psilocybin (magic mushrooms) will induce profound changes in consciousness and perceptio...

March 29, 2022 | Tuesday | News
New Zealand backs Parkinson's disease research with new grant

  A team of researchers- Professor Leigh Hale and Dr Paulo Henrique Silva Pelicioni, of the School of Physiotherap...

March 28, 2022 | Monday | News
Fujifilm buys Shenandoah Biotechnology to strengthen life sciences biz

Japan-based FUJIFILM Corporation has announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development ...

March 23, 2022 | Wednesday | News
Australia invests $28.1 M to establish new Genomics agency

Through its 10-year Medical Research Future Fund (MRFF) plan, the Australian government is helping Australians live long...

March 22, 2022 | Tuesday | News
Singapore links genetic ancestry with childhood leukaemia treatment success

Researchers from Singapore's NUS Yong Loo Lin School of medicine and St Jude Children’s Research Hospital in the U...

March 21, 2022 | Monday | News
Australia suggests new therapy to stabilise plaques associated with heart attack

A novel new therapy has been found to reduce harmful plaque in arteries and change its composition so it is less likely ...

March 21, 2022 | Monday | News
Korea shows AI tool as novel biomarker for immunotherapy response

Lunit, a South Korea-based startup has announced the publication of its study in the Journal of Clinical Oncology (JCO)....

March 18, 2022 | Friday | News
Singapore develops novel method of delivering drugs into human cells

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a novel method of delivering ...

March 16, 2022 | Wednesday | News